Linear mixed models for longitudinal data G Verbeke, G Molenberghs, G Verbeke Linear mixed models in practice: A SAS-oriented approach, 63-153, 1997 | 6973 | 1997 |
The prevention and treatment of missing data in clinical trials RJ Little, R D'agostino, ML Cohen, K Dickersin, SS Emerson, JT Farrar, ... New England Journal of Medicine 367 (14), 1355-1360, 2012 | 2242* | 2012 |
Missing data in clinical studies G Molenberghs, M Kenward John Wiley & Sons, 2007 | 1297 | 2007 |
Longitudinal data analysis G Fitzmaurice, M Davidian, G Verbeke, G Molenberghs CRC press, 2008 | 1033 | 2008 |
Linear mixed models in practice: a SAS-oriented approach G Verbeke, G Molenberghs Springer Science & Business Media, 2012 | 1030 | 2012 |
The dysphonia severity index: an objective measure of vocal quality based on a multiparameter approach FL Wuyts, MSD Bodt, G Molenberghs, M Remacle, L Heylen, B Millet, ... Journal of speech, language, and hearing research 43 (3), 796-809, 2000 | 870 | 2000 |
The validation of surrogate endpoints in meta-analyses of randomized experiments M Buyse, G Molenberghs, T Burzykowski, D Renard, H Geys Biostatistics 1 (1), 49-67, 2000 | 680 | 2000 |
Missing data methods in longitudinal studies: a review JG Ibrahim, G Molenberghs Test 18 (1), 1-43, 2009 | 579 | 2009 |
Analyzing incomplete longitudinal clinical trial data G Molenberghs, H Thijs, I Jansen, C Beunckens, MG Kenward, ... Biostatistics 5 (3), 445-464, 2004 | 552 | 2004 |
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009) N Adriaenssens, S Coenen, A Versporten, A Muller, G Minalu, C Faes, ... Journal of antimicrobial chemotherapy 66 (suppl_6), vi47-vi56, 2011 | 545 | 2011 |
Criteria for the validation of surrogate endpoints in randomized experiments M Buyse, G Molenberghs Biometrics, 1014-1029, 1998 | 541 | 1998 |
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis M Buyse, P Thirion, RW Carlson, T Burzykowski, G Molenberghs, ... The Lancet 356 (9227), 373-378, 2000 | 502 | 2000 |
Handbook of missing data methodology G Molenberghs, G Fitzmaurice, MG Kenward, A Tsiatis, G Verbeke CRC Press, 2014 | 412 | 2014 |
The evaluation of surrogate endpoints M Buyse, G Molenberghs Springer, 2005 | 409 | 2005 |
Marginal modeling of correlated ordinal data using a multivariate Plackett distribution G Molenberghs, E Lesaffre Journal of the American Statistical Association 89 (426), 633-644, 1994 | 405 | 1994 |
The analysis of multivariate longitudinal data: a review G Verbeke, S Fieuws, G Molenberghs, M Davidian Statistical methods in medical research 23 (1), 42-59, 2014 | 349 | 2014 |
High prevalence of foot diseases in Europe: results of the Achilles Project T Burzykowski, G Molenberghs, D Abeck, E Haneke, R Hay, A Katsambas, ... Mycoses 46 (11‐12), 496-505, 2003 | 316 | 2003 |
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals … N Conrad, S Misra, JY Verbakel, G Verbeke, G Molenberghs, PN Taylor, ... The Lancet 401 (10391), 1878-1890, 2023 | 313 | 2023 |
The use of score tests for inference on variance components G Verbeke, G Molenberghs Biometrics 59 (2), 254-262, 2003 | 306 | 2003 |
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data CH Mallinckrodt, TM Sanger, S Dubé, DJ DeBrota, G Molenberghs, ... Biological psychiatry 53 (8), 754-760, 2003 | 303 | 2003 |